Frontlight ResearchEarly access
Acute myeloid leukaemia trials in United States
334 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peoplePrevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
- Where
- Boston, Duarte, Minneapolis, New York, Seattle
- Age
- 18 years and over
- People
- 36
- Run by
- Tr1X, Inc.
See details and how to joinNCT06462365 - Phase 1Taking peopleA Clinical Trial of BP1002 in Patients With Refractory/Relapsed Acute Myeloid Leukemia (AML)
- Where
- Houston, La Jolla, Los Angeles, New York
- Age
- 18 years and over
- People
- 48
- Run by
- Bio-Path Holdings, Inc.
See details and how to joinNCT05190471 - Phase 1Taking peopleStudy of Oral PCLX-001 in R/R Acute Myeloid Leukemia
- Where
- Houston
- Age
- 18 years and over
- People
- 35
- Run by
- Pacylex Pharmaceuticals
See details and how to joinNCT06613217 - Phase 2Taking peopleClinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML
- Where
- Augusta, Brick, Fairway, Houston, Los Angeles, Morgantown, New York, Temple
- Age
- 18 years and over
- People
- 108
- Run by
- Bio-Path Holdings, Inc.
See details and how to joinNCT02781883 - Phase 1Taking peopleStudy of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies
- Where
- Birmingham, Cincinnati, Houston, Nashville, Seattle
- Age
- 18 years and over
- People
- 36
- Run by
- Vincerx Pharma, Inc.
See details and how to joinNCT06034275 - Phase 1/2Taking peopleSafety and Efficacy of Expanded, Universal Donor Natural Killer Cells for Relapsed/Refractory AML
- Where
- Columbus
- Age
- 1 year to 24 years
- People
- 20
- Run by
- Nationwide Children's Hospital
See details and how to joinNCT05503134 - Phase 2Taking peopleAzacitidine or Decitabine With Venetoclax for Acute Myeloid Leukemia With Prior Hypomethylating Agent Failure
- Where
- Clovis, Los Angeles, Oklahoma City, Sacramento
- Age
- 18 years and over
- People
- 20
- Run by
- Brian Jonas
See details and how to joinNCT04905810 - Phase 1Taking peopleA Study of BTX-A51 in People With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
- Where
- Duarte, Houston, New York
- Age
- 18 years and over
- People
- 80
- Run by
- Edgewood Oncology Inc.
See details and how to joinNCT04243785 - Phase 1Taking peopleStudy in Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome Patients to Determine the Recommended Dose of CYAD-02
- Where
- Fairway, Jacksonville
- Age
- 18 years and over
- People
- 27 worldwide
- Run by
- Celyad Oncology SA
See details and how to joinNCT04167696